View on GitHub

The following recent FDA approvals were added to the Molecular Oncology Almanac in this release -

Added entries:

  • (FDA) EGFR exon 20 insertion somatic variants and sensitivity to amivantamab-vmjw in metastatic non-small cell lung cancer.
  • (FDA) FGFR2 fusions and sensitivity to infigratinib in cholangiocarcinoma.
  • (FDA) KRAS p.G12C and sensitivity to sotorasib in non-small cell lung cancer.